Table 3.
Accurate Disclosurea of Serostatus | Experimental (Accurate Disclosure/Total Disclosure)(%) | Control (Accurate Disclosure/Total Disclosure)(%) |
---|---|---|
Men | ||
Baseline | 60/70 (86%) | 44/61 (72%) |
Post-Intervention | 76/92 (83%) | 46/58 (80%) |
Women | ||
Baseline | 95/119 (80%) | 83/119 (70%) |
Post-Intervention | 96/118 (81%) | 76/117 (65%) |
”Accurate disclosure” indicates participants whose partner correctly identified their HIV serostatus, and “total disclosure” includes those whose partner provided an inaccurate serostatus.